Reduced incidence of febrile neutropenia and related complications in elderly breast cancer patients receiving chemotherapy with pegfilgrastim primary prophylaxis versus current practice neutropenia management - results from an integrated analysis
Publication
, Conference
Aapro, M; Schwenkglenks, M; Lyman, G; Lopez Pousa, A; Easton, V; Skacel, T; Bacon, P; Von Minckwitz, G
Published in: BREAST CANCER RESEARCH AND TREATMENT
2007
Duke Scholars
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2007
Volume
106
Start / End Page
S72 / S72
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Aapro, M., Schwenkglenks, M., Lyman, G., Lopez Pousa, A., Easton, V., Skacel, T., … Von Minckwitz, G. (2007). Reduced incidence of febrile neutropenia and related complications in elderly breast cancer patients receiving chemotherapy with pegfilgrastim primary prophylaxis versus current practice neutropenia management - results from an integrated analysis. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 106, pp. S72–S72).
Aapro, M., M. Schwenkglenks, G. Lyman, A. Lopez Pousa, V. Easton, T. Skacel, P. Bacon, and G. Von Minckwitz. “Reduced incidence of febrile neutropenia and related complications in elderly breast cancer patients receiving chemotherapy with pegfilgrastim primary prophylaxis versus current practice neutropenia management - results from an integrated analysis.” In BREAST CANCER RESEARCH AND TREATMENT, 106:S72–S72, 2007.
Aapro M, Schwenkglenks M, Lyman G, Lopez Pousa A, Easton V, Skacel T, et al. Reduced incidence of febrile neutropenia and related complications in elderly breast cancer patients receiving chemotherapy with pegfilgrastim primary prophylaxis versus current practice neutropenia management - results from an integrated analysis. In: BREAST CANCER RESEARCH AND TREATMENT. 2007. p. S72–S72.
Aapro, M., et al. “Reduced incidence of febrile neutropenia and related complications in elderly breast cancer patients receiving chemotherapy with pegfilgrastim primary prophylaxis versus current practice neutropenia management - results from an integrated analysis.” BREAST CANCER RESEARCH AND TREATMENT, vol. 106, 2007, pp. S72–S72.
Aapro M, Schwenkglenks M, Lyman G, Lopez Pousa A, Easton V, Skacel T, Bacon P, Von Minckwitz G. Reduced incidence of febrile neutropenia and related complications in elderly breast cancer patients receiving chemotherapy with pegfilgrastim primary prophylaxis versus current practice neutropenia management - results from an integrated analysis. BREAST CANCER RESEARCH AND TREATMENT. 2007. p. S72–S72.
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
2007
Volume
106
Start / End Page
S72 / S72
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences